Astellas Pharma Inc (4503) - Medical Equipment - Deals and Alliances Profile

Astellas Pharma Inc (4503) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME27458D
  • |
  • Pages: 78
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Astellas Pharma Inc (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company's product portfolio comprises both marketed and pipeline products for the treatment of a wide range of diseases in the areas of urology, transplantation, immune deficiency, infectious diseases, cancer, neuroscience, and metabolic diseases, among others. The company sells its products under the brand names such as Prograf, Vesicare, Geninax, and Eligard among others. It has operations in several countries across the Americas; Europe, Asia and Oceania through its network of subsidiaries and affiliates. Astellas is headquartered in Tokyo, Japan.

Astellas Pharma Inc (4503)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Astellas Pharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Astellas Pharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Astellas Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Astellas Pharma Inc, Medical Equipment, Deal Details 11

Venture Financing 11

Euroscreen Raises USD17.8 Million in Series B Financing Round 11

Ganymed Pharmaceuticals Secures USD60.74 Million in Venture Funding 13

Partnerships 14

Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 14

Qiagen Enters into Co-Development Agreement with Astellas Pharma 16

Astellas Pharma Enters Into Co-Marketing Agreement With Nippon Kayaku For A670 17

Equity Offering 18

Advanced Cell to Raise USD30 Million in Private Placement of Shares 18

Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For USD 35 Million 19

Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For USD 1 Million 20

Acquisition 21

Astellas Pharma Acquires Ganymed Pharma 21

Astellas Pharma Inc-Key Competitors 23

Astellas Pharma Inc-Key Employees 24

Astellas Pharma Inc-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Joint Venture 34

Recent Developments 35

Financial Announcements 35

Apr 26, 2018: Astellas Reports Financial Results for FY2017 35

Jan 31, 2018: Astellas Reports Financial Results for the First Nine Months of FY2017 37

Oct 31, 2017: Astellas Reports First Half FY2017 Financial Results, Revises Fiscal Year Outlook 39

Jul 28, 2017: Astellas Reports First Quarter FY2017 Financial Results 41

Apr 27, 2017: Astellas Reports Full Year FY2016 Financial Results 43

Jan 31, 2017: Astellas Reports the First Nine Months Financial Results of FY2016 45

Corporate Communications 46

Sep 18, 2018: Astellas Promotes Geoff Towle to Vice President of Oncology Marketing at Astellas US 46

Aug 23, 2018: Astellas announces promotion of Rodrigo Fernandez to Vice President, Latin America 47

Jun 08, 2018: Astellas names Nahrin Marino to Vice President, Head of Ethics & Compliance Americas 48

May 15, 2018: Astellas Names Bernhardt Zeiher As New Chief Medical Officer 49

Mar 28, 2018: Astellas Appoints Tatjana Dragovic, J.D. Head of Ethics & Compliance 50

Mar 15, 2018: Astellas Names Percival Barretto-Ko President, Americas Operations 51

Mar 13, 2018: Astellas Announces Key Leadership Changes in Legal, Human Resources 52

Jan 31, 2018: Astellas Appoints Kenji Yasukawa as President and CEO 53

Jan 08, 2018: Astellas Announces Leadership Changes in Canada and U.S. 54

Dec 13, 2017: Astellas Appoints Anthony Fiordaliso to Vice President, Americas Finance 55

Dec 04, 2017: Astellas Appoints Joao Carlos de Britto as General Manager of Astellas Farma Brasil 56

Dec 01, 2017: Astellas Announces Personnel Change 57

Nov 01, 2017: Astellas Announces Leadership Changes in U.S. Health Systems Commercial Organization 58

Oct 31, 2017: Astellas Appoints Nate Crisel to Vice President, Real World Informatics & Analytics 59

Oct 30, 2017: Astellas Appoints Gary Thal, M.D., to Vice President, Specialty, Medical Affairs, Americas 60

Aug 24, 2017: Astellas Announces Personnel Changes and Organizational Changes 61

Jun 26, 2017: Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations 62

May 11, 2017: Astellas Names Shontelle Dodson Senior Vice President and Head of Medical Affairs Americas 63

Apr 28, 2017: Astellas Announces Key Leadership Promotions in Development Organization 64

Apr 27, 2017: Astellas Pharma Announces Changes of Representative Directors and Directors 65

Feb 08, 2017: Astellas Announces Changes in Management Structure and Global Function 67

Feb 08, 2017: Astellas Announces Personnel Changes and Organizational Changes 68

Legal and Regulatory 70

May 31, 2017: Astellas Announces New Global Website Launch 70

Government and Public Interest 71

May 31, 2018: Astellas Oncology C3 Prize Returns for Third Year with Focus on Improving Cancer Care in Underserved Regions of the World 71

Jul 05, 2017: Astellas Named to FTSE4Good Sustainability Index for the Sixth Consecutive Year 72

Other Significant Developments 73

Feb 05, 2018: Astellas Announces Changes in Management Structure, Global Function, and Top Management Committees 73

Feb 05, 2018: Astellas Announces Organizational Changes 74

Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma 75

Appendix 78

Methodology 78

About GlobalData 78

Contact Us 78

Disclaimer 78

List of Figures

Astellas Pharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Astellas Pharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Astellas Pharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

Astellas Pharma Inc, Medical Equipment, Key Facts, 2018 2

Astellas Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Astellas Pharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Astellas Pharma Inc, Deals By Market, 2012 to YTD 2018 9

Astellas Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Euroscreen Raises USD17.8 Million in Series B Financing Round 11

Ganymed Pharmaceuticals Secures USD60.74 Million in Venture Funding 13

Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 14

Qiagen Enters into Co-Development Agreement with Astellas Pharma 16

Astellas Pharma Enters Into Co-Marketing Agreement With Nippon Kayaku For A670 17

Advanced Cell to Raise USD30 Million in Private Placement of Shares 18

Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For USD 35 Million 19

Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For USD 1 Million 20

Astellas Pharma Acquires Ganymed Pharma 21

Astellas Pharma Inc, Key Competitors 23

Astellas Pharma Inc, Key Employees 24

Astellas Pharma Inc, Key Employees (cont..) 27

Astellas Pharma Inc, Other Locations 28

Astellas Pharma Inc, Subsidiaries 28

Astellas Pharma Inc, Joint Venture 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Astellas Pharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 18445
Site License
USD 500 INR 36890
Corporate User License
USD 750 INR 55335

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com